This article is a correction to:
Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types
Youngae Lee1,2,3†
Jang-Hee Oh1,2,3†Na Li1,2,3,4
Hyun-Jae Jang5Kyung-Seop Ahn5
Sei-Ryang Oh5
Dong Hun Lee1,2,3
Jin Ho Chung1,2,3,4*- 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea
- 2Institute of Human-Environment Interface Biology, Medical Research Center, Seoul National University, Seoul, Republic of Korea
- 3Laboratory of Cutaneous Aging Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
- 4Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Republic of Korea
- 5Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheong-ju, Chungcheongbuk-do, Republic of Korea
A Corrigendum on
Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types
by Lee Y, Oh J-H, Li N, Jang H-J, Ahn K-S, Oh S-R, Lee DH, and Chung JH (2022) 13:1064515. doi: 10.3389/fimmu.2022.1064515
In the published article, there was an error in the author list, and authors Youngae Lee and Jang-Hee Oh were erroneously not annotated as co-first authors. The corrected author list appears below.
Youngae Lee1,2,3†, Jang-Hee Oh1,2,3†, Na Li1,2,3,4, Hyun-Jae Jang5, Kyung-Seop Ahn5, Sei-Ryang Oh5, Dong Hun Lee1,2,3 and Jin Ho Chung1,2,3,4*
† These authors have contributed equally to this work.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Skullcapflavone II, atopic dermatitis, pruritus, Th2 cytokines, IgE
Citation: Lee Y, Oh J-H, Li N, Jang H-J, Ahn K-S, Oh S-R, Lee DH and Chung JH (2023) Corrigendum: Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types. Front. Immunol. 14:1150830. doi: 10.3389/fimmu.2023.1150830
Received: 25 January 2023; Accepted: 27 January 2023;
Published: 07 February 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Lee, Oh, Li, Jang, Ahn, Oh, Lee and Chung. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jin Ho Chung, jhchung@snu.ac.kr
†These authors have contributed equally to this work